SCHEMBL6441200

SCHEMBL6441200

Cc1cc(C)c(CO)c(O)c1CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
PGK1 P00558 1/20 0.38
PGK2 P07205 1/20 0.38
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
ERBB2 P04626 1/20 0.36
PIM1 P11309 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
TRPA1 O75762 1/20 0.35
DRD4 P21917 1/20 0.35
SLC11A2 P49281 1/20 0.34
AKR1B1 P15121 1/20 0.34
SELL P14151 1/20 0.33
SELP P16109 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13866611 0.85 KDM4E (0.48) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL28585139 0.82 SHBG (0.42) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8346909 0.81 ALDH1A1 (0.43) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL7708095 0.80 PGK1 (0.50) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL9064773 0.78 ESR1 (0.41) SHBGALDH1A1KDM4EHPGDCA1
SCHEMBL3469757 0.78 CYP3A4 (0.48) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL28694874 0.76 HTT (0.43) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5141818 0.76 IDO1 (0.39) ALDH1A1AKR1B1MAPT
SCHEMBL360246 0.76 PGK1 (0.41) SHBGALDH1A1KDM4EHPGDHSD17B10
SCHEMBL95192 0.74 HRH3 (0.40) ALDH1A1KDM4ECA1CA2PGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919456-B2 Catalytic compositions and methods for asymmetric aldol reactions THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2005-07-19 US disclosed
EP-1409122-A2 CATALYTIC COMPOSITIONS AND METHODS FOR ASYMMETRIC ALDOL REACTIONS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2004-04-21 EP disclosed
US-20040019239-A1 Catalytic compositions and methods for asymmetric aldol reactions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-01-29 US disclosed
US-6610889-B2 Using organometallic complex catalyst THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2003-08-26 US disclosed
US-20020147367-A1 Catalytic compositions and methods for asymmetric aldol reactions NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-10-10 US disclosed
WO-2002041984-A2 CATALYTIC COMPOSITIONS AND METHODS FOR ASYMMETRIC ALDOL REACTIONS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2002-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147367-A1 Catalytic compositions and methods for asymmetric aldol reactions ADH1C, ADH5, ADH1A SHBG 2504/4885ALDH1A1 26/4885KDM4E 3834/4885
US-20040019239-A1 Catalytic compositions and methods for asymmetric aldol reactions ADH1C, ADH5, ADH1A SHBG 2504/4885ALDH1A1 26/4885KDM4E 3834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.